Trial intelligence / Profile preview

Low-dose hCG added to short GnRH agonist/rFSH IVF protocol in older infertile women

2016-005208-24Phase 3Terminated

Sponsor
Prof. Harry Siristatidis
Start
May 2017
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of human chorionic gonadotropin in female infertility, sponsored by Prof. Harry Siristatidis. Started May 2017; status: terminated.

02

Drugs

human chorionic gonadotropin
03

Conditions

female infertility

Beyond the preview

Go deeper on 2016-005208-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-005208-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call